Sage Journals: Discover world-class research

Abstract

Purpose

The kappa opioid receptor (KOR) plays a pivotal role in stress- and anxiety-related behaviors, with growing evidence linking it to stress induced by social isolation and separation. Despite this, tools for studying KOR in clinically relevant social contexts remain limited. The socially monogamous coppery titi monkey offers a translational model for investigating pair bonding. This study evaluated the feasibility of [¹¹C]GR103545 PET imaging to characterize KOR activity in vivo, and its pharmacological blockade for the first time in titi monkeys.

Methods

Adult titi monkeys (N = 6) underwent [¹¹C]GR103545 PET brain scans at baseline and following administration of the KOR antagonist CERC-501. Non-displaceable binding potential (BP_ND) was calculated across 14 brain volumes of interest (VOIs) implicated in social bonding, using Simplified and Logan reference tissue models (SRTM and LRTM), with the cerebellum as the reference region.

Results

Baseline [¹¹C]GR103545 uptake patterns across VOIs were consistent with reports in humans, other primates and published autoradiography data. CERC-501 pretreatment significantly reduced BP_ND (SRTM: 55.99%, LRTM: 59.68%) across several, but not all brain VOIs.

Conclusions

This study establishes [¹¹C]GR103545 PET as a viable tool for assessing KOR binding dynamics in titi monkeys, providing new opportunities to explore KOR modulation in social bonding and separation.

Keywords

antagonist kappa opioid receptor non-displaceable binding potential positron emission tomography reference tissue modeling titi monkey

Introduction

Kappa opioid receptors (KORs), the most abundant subtype of the opioid receptors, play a central role in a wide range of neurophysiological functions pertaining to regulation of mood and motivation.^1,2 Given their antidepressant-like effects, KOR antagonists are being actively explored as therapeutics for stress-related disorders,^3,4 including in ongoing clinical trials for CERC-501 (NCT06514742).⁵ Activation of KOR by its only endogenous ligand, dynorphin, in response to stress has been strongly associated with aversive behavior regulation in humans.^6–8 Social stressors, such as social isolation and separation have been shown to trigger KOR activation in preclinical models.^9–11 However, the mechanisms by which KOR influences critical social neurotransmitters like oxytocin (OT) remain unclear. The widespread loneliness reported during the COVID-19 pandemic underscored the profound psychological impact of these social stressors on human health.^12,13 Therefore, now more than ever, it is crucial to understand the role of KOR in social stress and its potential for pharmacologic targeting.

Positron Emission Tomography (PET) has been widely utilized for imaging the opioid system^14–17 with several radiotracers developed to provide a readout for the KOR.^18–21 In particular, the radiotracer [¹¹C]GR103545, a highly selective KOR agonist,²² has provided valuable, in vivo insights into KOR activity in humans. Studies in major depressive disorder²³ and substance use disorder²⁴ have reported reduced radiotracer binding in individuals experiencing higher stress and also following drug intake. These findings suggest that [¹¹C]GR103545 PET is a useful tool to track KOR modulation. However, assessing these dynamics with regard to social isolation requires clinically relevant animal models that closely emulate human social attachment. Traditional models such as mice, rats and rhesus macaques lack the capacity to form long-term pair bonds comparable to humans.^25–28

The coppery titi monkey (Plecturocebus cupreus), a socially monogamous South American non-human primate, serves as an exceptional translational model for studying human-like pair bonds. These monkeys exhibit hallmark characteristics of human adult pair bonding, including familiar partner preference, distress upon separation (social separation), and social buffering, which is when the presence of the partner modulates their stress response.²⁹ They also demonstrate OT release patterns similar to humans,³⁰ such as elevated OT levels upon separation from their partner.^29,31 These unique traits make titi monkeys a robust animal model to analyze KOR (and its interactions with OT) in the broader context of social relationships.

To date, no PET studies analyzing the KOR have been conducted in titi monkeys, despite their high relevance to human social bonding. To address this unmet need, the aim of this study was to characterize the distribution and binding of the radiotracer [¹¹C]GR103545, in the titi monkey brain. Additionally, we evaluated radiotracer binding dynamics following pharmacological blockade of KOR with the antagonist CERC-501, providing the first in vivo assessment of KOR modulation in this species.

Materials and Methods

Animals

All experiments with animals were approved by the University of California Davis Institutional Animal Care and Use Committee (IACUC; protocol number: 23483) and used facilities fully accredited by American Association for Accreditation of Laboratory Animal Care (AAALAC) International. Six adult coppery titi monkeys (3 male, 3 female; 7.0 ± 1.5 year old; 1.22 ± 0.15 kg), born and housed at the California National Primate Research Center, were selected for this study. As this was a pilot study designed to assess feasibility, a formal sample size calculation was not performed. All subjects were socially housed in cages (1.2 m × 1.2 m × 2.1 m) under a 12:12 light:dark cycle with temperature maintained at 21 °C.

PET Imaging Protocol and Pretreatment

The PET radiotracer [¹¹C]GR103545 was synthesized as described in³² with a mean molar activity of 155.02 ± 30.63 PBq/mol at the end of synthesis. Titi monkeys were anesthetized with 1–2% isoflurane and positioned head-first on a custom bed of a dedicated brain PET scanner (PiPET, Brain Biosciences, Rockville, MD). The dynamic 110 min PET acquisition began approximately 15 s prior to injection of [¹¹C]GR103545 (injected activity 48.16 ± 6.27 MBq, injected mass 0.26 ± 0.04 µgm/kg; Figure 1). Data were reconstructed with an isotropic voxel size of 0.8 mm³ using framing of 6 × 10 s, 8 × 30 s, 5 × 60 s, 4 × 300 s, 8 × 600 s. A single-pass “cold” transmission scan was acquired pre-injection for attenuation and scatter correction. This PET imaging protocol was established and validated before the start of the study.

Figure 1.

The Scanning Paradigm for N = 6 Titi Monkeys, Imaged for 110-min (PET Emission Scan), at Two Timepoints; Baseline and 10-min After Pretreatment with Antagonist CERC-501. Imaging Sessions for Each Animal Were Conducted with a Minimum Interval of one Month Between Them.

Blocking experiments involved pre-treatment with KOR antagonist CERC-501 (Supplier: MedChemExpress, Monmouth Junction, NJ, Cat. No.: HY-101718), administered (0.3 mg/kg, i.v.) to the same n = 6 titi monkeys, 10-min prior to radiotracer administration.³³ Imaging sessions were spaced at least one month apart per animal.

Magnetic Resonance Imaging (MRI) Acquisition

To aid with regional delineation, anatomical T₁-weighted brain MRIs were acquired with a 1.5 T GE Signa LX9.1 scanner (General Electric Corporation, Milwaukee, WI) and a 3” surface coil. The MR acquisition employed a 3D spoiled gradient echo pulse sequence in the coronal plane using the following parameters: echo time (TE) = 7.9 ms, repetition time (TR) = 22.0 ms, flip angle=30.0°, field of view=8 cm, number of excitations=3, matrix=256 × 256, resulting in a pixel size of 0.3125 × 0.3125 mm² and a slice thickness of 1 mm.

Image Post Processing and Kinetic Modeling

Anatomical MRIs were mapped to a titi monkey reference space using rigid registration and processed with BrainSuite (v23a)³⁴ for skull-stripping and N4ITK for bias-correction.³⁵ A titi monkey brain atlas was warped to each MRI using symmetric normalization (Advanced Normalization Tools)^36,37 to generate regional labels, refined as needed by a neuroanatomy expert. PET data were motion-corrected and coregistered to MRIs on PMOD (v4.4, PMOD Technologies, Zürich, Switzerland). The image analysis pipeline is shown in Supplementary Figure S1.

Region-specific, non-displaceable binding potential (BP_ND) was calculated on PMOD utilizing the Simplified Reference Tissue Model (SRTM)³⁸ and Logan Reference Tissue Model (LRTM),³⁹ each with the cerebellum as the reference region. Reference tissue modeling has been validated for this radiotracer in previous studies across species.^22,33,40,41 SRTM and LRTM were compared to identify the best fit for the dynamic data. For LRTM, the average tissue-to-plasma clearance k₂’ was estimated from SRTM and t* was set at 40 min. The primary analysis included 14 brain volumes of interest (VOIs) relevant to social bonding, namely, nucleus accumbens, caudate, hypothalamus, cingulate, hippocampus, amygdala, claustrum, orbitofrontal cortex, thalamus, septum, superior frontal gyrus, superior temporal gyrus, insula, and putamen. Additionally, the pituitary gland, showing high PET signal, was delineated with a spherical VOI.

Statistical Analysis

BP_ND differences between baseline and antagonist conditions were analyzed using one-way nonparametric ANOVA for matched pairs (Friedman test; GraphPad Prism v10.0.2).⁴² Multiple comparisons were accounted for by controlling the false discovery rate (FDR).⁴³ Pearson's correlation assessed agreement between BP_ND calculated from the SRTM and LRTM. Goodness of fit for kinetic models was evaluated using the Akaike Information Criteria (AIC)⁴⁴ reported in PMOD. The significance threshold was set at 0.05.

Results

Baseline BP_ND Concurred with Reported Distribution of KOR in the Titi Monkey Brain

Representative [¹¹C]GR103545 uptake patterns at baseline and after pre-treatment by CERC-501 are shown in Figure 2. Regional time-activity curves are shown in Figure 3. Baseline uptake patterns were consistent with autoradiography studies of KOR density in the titi monkey brain.⁴⁵ Correspondingly, high BP_ND (> 1.3) was observed in the pituitary gland followed by the insula, claustrum and orbitofrontal cortex. Moderate BP_ND (0.9-1.3) was detected in VOIs including (but are not limited to) the nucleus accumbens, amygdala, and hippocampus, while the thalamus exhibited low BP_ND.

Figure 2.

[¹¹C]GR103545 PET (Color) Overlaid onto T₁-weighted MRI of a Titi Monkey in the Axial (A, C) and Sagittal (B, D) Plane for Baseline (A, B) and CERC-501 Pretreatment (C, D) Scans. Reduced Radiotracer Uptake in the Brain is Apparent after Pretreatment with CERC-501 (C, D). PET Data are Presented as Standardized Uptake Value (SUV) Images Calculated from Data 80-110 min Post-radiotracer Injection.

Figure 3.

[¹¹C]GR103545 PET Time Activity Curves Across Selected Volumes of Interest (VOIs) for a Representative Titi Monkey at Baseline. Points Indicate Measured Standard Uptake Value (SUV) While the Solid Line Indicates the fit with Simplified Reference Tissue Model (SRTM).

Model fits based on SRTM showed a median AIC of −10.73 (range: −32.41 to 36.47), while LRTM exhibited a median AIC of 68.55 (range: 59.02 to 78.15) (Supplementary Table S1). These results suggest that SRTM provided a better fit for the dynamic PET data compared to LRTM.

Pretreatment with CERC-501 Significantly Reduced Binding Across Several, but not all, VOIs When Compared to Baseline BP_ND

CERC-501 administration significantly reduced BP_ND across most VOIs, with an average reduction of 55.99% (SRTM) and 59.68% (LRTM). For SRTM, significant reductions were observed in all VOIs except the claustrum, hypothalamus, and septum (Figure 4). The superior frontal gyrus showed the largest decrease (76.25%, p = 0.004) while the pituitary gland the smallest (27.69%, p = 0.021) (Table 1). For LRTM, binding reductions were significant across all VOIs except the nucleus accumbens, claustrum, septum and pituitary (Figure 5, Supplementary Figure S2). Similar to SRTM, the superior frontal gyrus showed the largest decrease (78.79%, p = 0.021) and the pituitary the smallest (23.21%, p = 0.149) (Table 2).

Figure 4.

BP_ND Across the 15 VOIs Calculated with SRTM for Baseline (CTR) and after CERC-501 Pretreatment (ANT). * Indicates Significant Difference after FDR Correction. The Points Indicate Individual Datapoints, While the Bars Indicate the 95% Confidence Interval.

Figure 5.

BP_ND Across the 15 VOIs Calculated with Logan Reference Tissue Model (LRTM) for Baseline (CTR) and After CERC-501 Pretreatment (ANT). * Indicates Significant Difference After FDR Correction. the Points Indicate Individual Datapoints, While the Bars Indicate the 95% Confidence Interval.

Table 1.

BP_ND Calculated with SRTM Averaged Across N = 6 Titi Monkeys in the 15 VOIs Scanned at Baseline and After CERC-501 Pretreatment, Their Corresponding p Values upon Comparing Baseline BP_ND to BP_ND After CERC-501 Pretreatment. the Reported p-Values are Before FDR Correction, While the Asterisk Denotes Comparisons That Survived FDR Correction.

VOIs	Baseline	Antagonist CERC-501
VOIs	Mean BP_ND	Mean BP_ND	p value (ANT vs CTR)
Amygdala	1.25	0.54	0.004 *
Caudate	1.04	0.41	0.004 *
Cingulate	1.53	0.49	0.004 *
Claustrum	1.72	0.94	0.083
Hippocampus	0.96	0.39	0.004 *
Hypothalamus	0.95	0.45	0.043
Insula	1.76	0.76	0.004 *
Nucleus accumbens	1.27	0.52	0.021 *
Orbitofrontal cortex	1.56	0.79	0.004 *
Pituitary	1.78	1.29	0.021 *
Putamen	1.3	0.57	0.009 *
Septum	1.21	0.51	0.083
Superior frontal gyrus	1.39	0.33	0.004 *
Superior temporal gyrus	1.13	0.41	0.004 *
Thalamus	0.43	0.21	0.021 *

Indicates significance after FDR correction.

Table 2.

BP_ND Calculated Using with LRTM Averaged Across N = 6 Titi Monkeys in the 15 VOIs Scanned at Baseline and After CERC-501 Pretreatment, Their Corresponding p Values upon Comparing Baseline BP_ND to BP_ND After CERC-501 Pretreatment. the Reported p-Values are Before FDR Correction, While the Asterisk Denotes Comparisons That Survived FDR Correction.

VOIs	Baseline	Antagonist CERC-501
VOIs	Mean BP_ND	Mean BP_ND	p value (ANT vs CTR)
Amygdala	1.16	0.49	0.004 *
Caudate	1.19	0.42	0.021 *
Cingulate	1.75	0.5	0.004 *
Claustrum	2.01	0.99	0.083
Hippocampus	0.95	0.37	0.009 *
Hypothalamus	0.94	0.31	0.004 *
Insula	2.07	0.81	0.009 *
Nucleus accumbens	1.39	0.49	0.043
Orbitofrontal cortex	1.78	0.82	0.009 *
Pituitary	1.48	1.14	0.149
Putamen	1.53	0.61	0.009 *
Septum	1.28	0.48	0.061
Superior frontal gyrus	1.64	0.35	0.021 *
Superior temporal gyrus	1.31	0.44	0.004 *
Thalamus	0.46	0.22	0.021 *

Indicates significance after FDR correction.

BP_ND Measured from SRTM Correlated with That from the LRTM Analysis

BP_ND values from STRM and LRTM showed a strong positive correlation (R = 0.94, p < 0.001; Supplementary Figure S3). Reductions in the claustrum and septum were not significant for both models. Unlike SRTM, LRTM reported no reduction in the nucleus accumbens and pituitary gland while SRTM reported no reduction in the hypothalamus. Overall, LRTM estimated a slightly greater reduction in BP_ND following CERC-501 pretreatment (59.68%) compared to SRTM (55.99%).

Discussion

This study is the first to use PET imaging to analyze KOR binding in titi monkeys, a species uniquely suited for translational studies due to their physiological similarities to humans and complex social behaviors.^14,16 The observed distribution of [¹¹C]GR103545 in the titi monkey brain aligned with previously reported autoradiographic findings.⁴⁵ Furthermore, significant reductions in [¹¹C]GR103545 BP_ND following CERC-501 administration confirmed the utility of this radiotracer for assessing KOR modulation in vivo in this animal model.

Most brain VOIs showed reduced BP_ND after CERC-501 pretreatment, a compound that is highly selective to the KOR.^5,46,47 This is consistent with findings from previous [¹¹C]GR103545 antagonist blocking experiments performed with naltrexone (an opioid antagonist) and PF04455242 (a KOR antagonist) in baboons⁴¹ and humans,⁴⁸ respectively. Self-blocking of [¹¹C]GR103545 in rhesus monkeys,²² and blocking using a range of antagonists and agonists in rats,³³ have also reported significant reductions in BP_ND. These results combined with the high selectivity of CERC-501 for mammalian KOR,⁵ support the utility of [¹¹C]GR103545 PET for in vivo evaluation of KOR modulation post administration of pharmacological therapies that target the KOR, reinforcing its translational relevance.

The highest BP_ND in the brain was reported in the insula, a finding consistent with its involvement in experiences of pain,⁴⁹ anxiety⁵⁰ and addiction⁵¹ in humans. Preclinical studies have implicated insular KOR activation⁵² in addiction circuits, particularly in alcohol use disorder.⁵³ Correspondingly, reduced uptake of the KOR antagonist radiotracer [¹¹C]LY2795050 in the insula has been reported in alcohol-dependent individuals compared to healthy controls.⁵⁴ Another region of interest, the nucleus accumbens also demonstrated BP_ND reduction in our study after CERC-501 administration. Dysregulation of KOR in this region has been linked to stress-related decreases in social motivation.^9,55–57 Conversely, the septum did not exhibit significant reductions following CERC-501 treatment with either the SRTM or LRTM fits. Being a moderate KOR binding region, it may have been less responsive to the blockade. Additionally, functional compensation by other opioid systems could have also contributed to the diminished KOR activity in this region.^58,59 Similarly, the claustrum, a region with dense KOR expression⁴⁵ also did not show significant reductions with either modeling method. This outcome could be influenced by the study's small sample size and limitations in segmentation accuracy due to the scan resolution for this anatomically narrow region. Given the roles of these regions in pair-bonding,^57,60–62 further investigation into KOR activity under various social experimental conditions in titi monkeys could provide valuable insights into the neurobiological underpinnings of social bonding in these brain regions.

Several radiotracers have been developed to evaluate KOR fluctuations in vivo for PET.^63–65 Among KOR agonist radiotracers, [¹¹C]GR89696, an isomer and precursor of [¹¹C]GR103545, has been reported to exhibit a homogeneous distribution in the brain but with limitations in binding specificity.⁶⁶ More recently, [¹¹C]EKAP and [¹¹C]FEKAP¹⁸ offer faster kinetics than [¹¹C]GR103545. While these more recent radiotracers offer compelling options for PET imaging, our selection of [¹¹C]GR103545 was based on its prevalent reporting within the literature. As for KOR antagonist tracers, [¹¹C]LY2795050, is the most widely used radiotracer for KOR PET. However, rodent studies have reported no change in [¹¹C]LY2795050 binding post KOR blockade.³³ The current study utilized [¹¹C]GR103545 due to its demonstrated high KOR binding affinity across rodent,³³ non-human primate,^22,40,41 and human studies.⁴⁸ Particularly, studies have also reported the ability of [¹¹C]GR103545 to selectively bind to the KOR in comparison to other opioid receptor subtypes (mu and delta opioid receptors).^40,48 While a comparative evaluation of KOR-specific radiotracers was beyond the scope of this study, such an analysis represents a promising avenue for future research. Furthermore, the small sample size of this study was insufficient to draw meaningful direct comparisons of KOR activity between sexes. Detection of sex-specific KOR activity remains the subject of future studies.

The use of reference tissue models for our study effectively addressed the challenges associated with arterial blood sampling in a longitudinal experimental paradigm for a monkey that weighs about 1 kg on average and therefore has limited blood volume compared to rhesus monkeys or baboons. Among the models tested, SRTM demonstrated a better fit to [¹¹C]GR103545 kinetics based on AIC metrics. While easier to implement, LRTM may be more sensitive to noise than SRTM and can introduce bias into the dataset.^40–42 Notably, it requires a careful selection of the linear phase (t*).^67–69 SRTM's ability to model the entire kinetic curve offers improved accuracy for smaller brain regions,⁷⁰ consistent with our results. However, due to the small brain size of the titi monkeys and resolution limit on the PET scanner, partial volume effects likely contributed to a likely underestimation of BP_ND in both methods. This phenomenon has also been reported in rhesus macaques using similar methods.^22,40

The utility of the cerebellum as a reference region remains a topic of debate,^22,24,48 although its suitability has been supported by studies in rats³³ and baboons.⁴¹ Further studies could explore whether arterial blood sampling provides greater sensitivity than reference region-based approaches. However, the invasive nature of arterial sampling presents challenges, particularly in longitudinal studies assessing stress responses or behavior, as the procedure itself may introduce confounders.

Conclusions

This study proposes [¹¹C]GR103545 PET in titi monkeys as an assessment tool with translational capability for further studying the role of KOR in clinically relevant stress-related behaviors resulting from social isolation, representing an advancement in our understanding of KOR dynamics in this setting. By demonstrating the feasibility of [¹¹C]GR103545 PET and its sensitivity to pharmacological modulation via CERC-501, we provide critical evidence supporting the utility of the radiotracer in titi monkeys. The findings underscore the potential of titi monkeys to bridge the gap between preclinical and human studies in understanding the neurobiological basis of social behaviors. Future investigations leveraging this monkey model could unravel the complex interplay between KOR and other neurochemical systems, such as OT, that shape social attachment and resilience to stress. This includes investigations in a longitudinal setting, offering pathways for therapeutic intervention in stress-related disorders.

Supplemental Material

sj-doc-1-mix-10.1177_15353508251341082 - Supplemental material for Mapping Kappa Opioid Receptor Binding in Titi Monkeys with [¹¹C]GR103545 PET

Supplemental material, sj-doc-1-mix-10.1177_15353508251341082 for Mapping Kappa Opioid Receptor Binding in Titi Monkeys with [¹¹C]GR103545 PET by Alita Jesal D Almeida, Brad A. Hobson, Logan E. Savidge, Claudia Manca, John P. Paulus, Karen L. Bales and Abhijit J. Chaudhari in Molecular Imaging

Footnotes

Acknowledgements

The authors would like to thank Joshua Waltenburg of the Center for Molecular and Genomic Imaging (CMGI) for synthesizing the radiotracer for this study and Charles Smith and Sarah Tam of CMGI for conducting the PET acquisitions.

ORCID iDs

Alita Jesal D Almeida

Brad A. Hobson

Abhijit J. Chaudhari

Ethical considerations

All experiments with animals were approved by the UC Davis Institutional Animal Care and Use Committee (IACUC protocol number: 23483) and used facilities fully accredited by AAALAC International.

Author Contributions

Alita Jesal D Almeida: Methodology, Software, Validation, Formal analysis, Investigation, Data Curation, Writing- Original Draft, Writing- Review & Editing.

Brad A. Hobson: Methodology, Software, Validation, Formal analysis, Investigation, Data Curation, Writing- Review & Editing, Supervision.

Logan Savidge: Methodology, Investigation, Data Curation, Writing- Review & Editing.

Claudia Manca: Methodology, Investigation, Data Curation, Writing- Review & Editing.

John P. Paulus: Methodology, Investigation, Data Curation, Writing- Review & Editing.

Karen L. Bales: Methodology, Investigation, Resources, Writing- Review & Editing, Supervision, Project administration, Funding acquisition.

Abhijit J. Chaudhari: Methodology, Investigation, Resources, Writing- Original Draft, Writing- Review & Editing, Supervision, Project administration, Funding acquisition.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health, (grant number P51 OD011107, R01 MH125411, S10 OD021715, U54 NS127758).

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Data Availability Statement

The datasets generated and/or analyzed for the current study will be available upon request.

Preprint:

Supplemental Material

Supplemental material for this article is available online.

References

James

Chavkin

Goldstein

. ##Selectivity of dynorphin for κ opioid receptors. Life Sci. 1982;31(12-13):1331–1334.

Crowley

Kash

. Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2015;62:51–60.

Jacobson

Browne

Lucki

. Kappa opioid receptor antagonists as potential therapeutics for stress-related disorders. Annu Rev Pharmacol Toxicol. 2020;60(1):615–636.

Mague

Pliakas

Todtenkopf

, et al. Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther. 2003;305(1):323–330.

Rorick-Kehn

Witkin

Statnick

, et al. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Neuropharmacology. 2014;77:131–144.

Land

Bruchas

Lemos

Melief

Chavkin

. The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system. J Neurosci. 2008;28(2):407–414.

Van’t Veer

Carlezon

. Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl). 2013;229(3):435–452.

Bruchas

Land

Chavkin

. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010;1314:44–55.

Bales

Rogers

. Interactions between the κ opioid system, corticotropin-releasing hormone and oxytocin in partner loss. Philos Trans R Soc, B. 2022;377(1858). DOI: https://doi.org/10.1098/rstb.2021.0061.

10.

Resendez

Kuhnmuench

Krzywosinski

Aragona

. κ-Opioid receptors within the nucleus accumbens shell mediate pair bond maintenance. J Neurosci. 2012;32(20):6771–6784.

11.

Resendez

Aragona

. Aversive motivation and the maintenance of monogamous pair bonding. Rev Neurosci. 2013;24(1). DOI: https://doi.org/10.1515/revneuro-2012-0068.

12.

Losada-Baltar

Martínez-Huertas

JÁ

Jiménez-Gonzalo

, et al. Longitudinal correlates of loneliness and psychological distress during the lockdown situation due to COVID-19. Effects of Age and Self-Perceptions of Aging. The Journals of Gerontology: Series B. 2022;77(4):652–660.

13.

Resendez

Keyes

Day

, et al. Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds. Elife. 2016;5. Epub ahead of print 2 July DOI: https://doi.org/10.7554/eLife.15325

14.

Cumming

Marton

Lilius

Olberg

Rominger

. A survey of molecular imaging of opioid receptors. Molecules. 2019;24(22):4190.

15.

Placzek

. Imaging Kappa opioid receptors in the living brain with positron emission tomography. 2021, pp. 547–577.

16.

Lever

. PET And SPECT imaging of the opioid system: Receptors, radioligands and avenues for drug discovery and development. Curr Pharm Des. 2007;13(1):33–49.

17.

Kaur

Wiesner

Kilbourn

Scott

. Classics in neuroimaging: Shedding light on opioid receptors with positron emission tomography imaging. ACS Chem Neurosci. 2020;11(19):2906–2914.

18.

Naganawa

Nabulsi

, et al. Kinetic modeling and test–retest reproducibility of 11C-EKAP and 11C-FEKAP, novel agonist radiotracers for PET imaging of the κ-opioid receptor in humans. J Nucl Med. 2020;61(11):1636–1642.

19.

Schmitt

Delamare

Tirel

, et al. N-[18F]-FluoropropylJDTic for κ-opioid receptor PET imaging: Radiosynthesis, pre-clinical evaluation, and metabolic investigation in comparison with parent JDTic. Nucl Med Biol. 2017;44:50–61.

20.

Cai

Pracitto

, et al. Fluorine-18-labeled antagonist for PET imaging of kappa opioid receptors. ACS Chem Neurosci. 2017;8(1):12–16.

21.

Cai

Zheng

, et al. Novel 18F-labeled κ-opioid receptor antagonist as PET radiotracer: Synthesis and in vivo evaluation of 18F-LY2459989 in nonhuman primates. J Nucl Med. 2018;59(1):140–146.

22.

Schoultz

Hjornevik

Willoch

, et al. Evaluation of the kappa-opioid receptor-selective tracer [11C]GR103545 in awake rhesus macaques. Eur J Nucl Med Mol Imaging. 2010;37(6):1174–1180.

23.

Miller

Zanderigo

Purushothaman

, et al. Kappa opioid receptor binding in major depression: A pilot study. Synapse. 2018;72(9). Epub ahead of print 17 September DOI: https://doi.org/10.1002/syn.22042.

24.

Martinez

Slifstein

Matuskey

, et al. Kappa-opioid receptors, dynorphin, and cocaine addiction: A positron emission tomography study. Neuropsychopharmacology. 2019;44(10):1720–1727.

25.

Witczak

Arias del Razo

Baxter

, et al. Relationships between cortisol and urinary androgens in female titi monkeys (Plecturocebus cupreus). Gen Comp Endocrinol. 2021;314:113927.

26.

Dolotovskaya

Walker

Heymann

. What makes a pair bond in a neotropical primate: Female and male contributions. R Soc Open Sci. 2020;7(1):191489.

27.

Bales

Ardekani

Baxter

, et al.

What is a pair bond?

Horm Behav. 2021;136:105062.

28.

Young

Wang

. The neurobiology of pair bonding. Nat Neurosci. 2004;7(10):1048–1054.

29.

Bales

Arias Del Razo

Conklin

, et al. Titi monkeys as a novel non-human primate model for the neurobiology of pair bonding. Yale J Biol Med. 2017;90(3):373–387.

30.

French

Taylor

Mustoe

Cavanaugh

. Neuropeptide diversity and the regulation of social behavior in new world primates. Front Neuroendocrinol. 2016;42:18–39.

31.

Savidge

Bales

. An animal model for mammalian attachment: Infant titi monkey (Plecturocebus cupreus) attachment behavior is associated with their social behavior as adults. Front Psychol. 2020;11. Epub ahead of print 28 January DOI: https://doi.org/10.3389/fpsyg.2020.00025

32.

Nabulsi

Zheng

Ropchan

, et al. [11c]GR103545: Novel one-pot radiosynthesis with high specific activity. Nucl Med Biol. 2011;38(2):215–221.

33.

Placzek

Schroeder

Che

, et al. Discrepancies in kappa opioid agonist binding revealed through PET imaging. ACS Chem Neurosci. 2019;10(1):384–395.

34.

Shattuck

Leahy

. Brainsuite: An automated cortical surface identification tool. Med Image Anal. 2002;6(2):129–142.

35.

Tustison

Avants

Cook

, et al. N4ITK: Improved N3 bias correction. IEEE Trans Med Imaging. 2010;29(6):1310–1320.

36.

Avants

Tustison

Johnson

. Advanced Normalization Tools (ANTS) Release 2.x, https://brianavants.wordpress.com/2012/04/13/updated-ants-compile-instructions-april-12-2012/ (2014).

37.

Avants

Epstein

Grossman

Gee

. Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal. 2008;12(1):26–41.

38.

Lammertsma

Hume

. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4(3):153–158.

39.

Logan

Fowler

Volkow

Wang

Ding

Alexoff

. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16(5):834–840.

40.

Tomasi

Nabulsi

Zheng

, et al. Determination of in vivo bmax and ki for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: A study in nonhuman primates. J Nucl Med. 2013;54(4):600–608.

41.

Talbot

Narendran

Butelman

, et al. 11C-GR103545, A radiotracer for imaging kappa-opioid receptors in vivo with PET: Synthesis and evaluation in baboons. J Nucl Med. 2005;46(3):484–494.

42.

Friedman

. The use of ranks to avoid the assumption of normality implicit in the analysis of variance. J Am Stat Assoc. 1937;32(200):675–701.

43.

Benjamini

Krieger

Yekutieli

. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93(3):491–507.

44.

Akaike

. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19(6):716–723.

45.

Ragen

Freeman

Laredo

Mendoza

Bales

. Μ and κ opioid receptor distribution in the monogamous titi monkey (Callicebus cupreus): Implications for social behavior and endocrine functioning. Neuroscience. 2015;290:421–434.

46.

Rorick-Kehn

Witcher

Lowe

, et al. Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human. Int J Neuropsuchopharmacolog. 2015;18(2). Epub ahead of print February DOI: https://doi.org/10.1093/ijnp/pyu036

47.

Domi

Barbier

Augier

, et al. Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders. Neuropsychopharmacology. 2018;43(9):1805–1812.

48.

Naganawa

Jacobsen

Zheng

, et al. Evaluation of the agonist PET radioligand [11C]GR103545 to image kappa opioid receptor in humans: Kinetic model selection, test–retest reproducibility and receptor occupancy by the antagonist PF-04455242. Neuroimage. 2014;99:69–79.

49.

Yang

Zhao

, et al. Insular cortex is critical for the perception, modulation, and chronification of pain. Neurosci Bull. 2016;32(2):191–201.

50.

Paulus

Stein

. An insular view of anxiety. Biol Psychiatry. 2006;60(4):383–387.

51.

Naqvi

Bechara

. The hidden island of addiction: The insula. Trends Neurosci. 2009;32(1):56–67.

52.

Pina

Pati

Hwa

, et al. The kappa opioid receptor modulates GABA neuron excitability and synaptic transmission in midbrain projections from the insular cortex. Neuropharmacology. 2020;165:107831.

53.

Pina

Pati

Neira

, et al. Insula dynorphin and kappa opioid receptor systems regulate alcohol drinking in a sex-specific manner in mice. J Neurosci. 2023;43(28):5158–5171.

54.

Vijay

Cavallo

Goldberg

, et al. PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age. Neuropsychopharmacology. 2018;43(13):2539–2547.

55.

Pagliusi

Franco

Cole

, et al. The BDNF-TrkB pathway acts through nucleus accumbens D2 expressing neurons to mediate stress susceptible outcomes. Front Psychiatry. 2022;13. DOI: https://doi.org/10.3389/fpsyt.2022.854494

56.

Kochunov

Kvarta

, et al. Reciprocal relationships between stress and depressive symptoms: The essential role of the nucleus accumbens. Psychol Med. 2024;54(5):1045–1056.

57.

Aragona

Liu

, et al. Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nat Neurosci. 2006;9(1):133–139.

58.

Knights

Henson

Morcom

Mitchell

Tsvetanov

. Neural evidence of functional compensation for fluid intelligence in healthy ageing. Epub ahead of print. 2024;13. DOI: https://doi.org/10.7554/eLife.93327.2.

59.

Bunzeck

Steiger

Krämer

, et al. Trajectories and contributing factors of neural compensation in healthy and pathological aging. Neurosci Biobehav Rev. 2024;156:105489.

60.

Zablocki-Thomas

Rogers

Bales

. Neuroimaging of human and non-human animal emotion and affect in the context of social relationships. Front Behav Neurosci. 2022;16. DOI: https://doi.org/10.3389/fnbeh.2022.994504.

61.

O'Connor

Wellisch

Stanton

Eisenberger

Irwin

Lieberman

. Craving love? Enduring grief activates brain’s reward center. Neuroimage. 2008;42(2):969–972.

62.

Aragona

Liu

Curtis

Stephan

Wang

. A critical role for nucleus accumbens dopamine in partner-preference formation in male prairie voles. J Neurosci. 2003;23(8):3483–3490.

63.

Noble

Dannals

Ravert

Wilson

Wagner

Jr . Synthesis of a radiotracer for studying k-subtype opiate receptors: N-[11C-methyl]-N-(trans-2-pyrrolidinyl-cyclohexyl)-3,4-dichlorophenylacetamide ([11C](±)U-50488H). J Labelled Comp Radiopharm. 1992;31(2):81–89.

64.

Ravert

Mathews

Musachio

Scheffel

Finley

Dannals

. [11c]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)methyl]-1-piperazinecarboxylate ([11C]GR89696): Synthesis and in vivo binding to kappa opiate receptors. Nucl Med Biol. 1999;26(7):737–741.

65.

Zheng

Nabulsi

Kim

, et al. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging. J Nucl Med. 2013;54(3):455–463.

66.

Ravert

Scheffel

Mathews

Musachio

Dannals

. [11c]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers. Nucl Med Biol. 2002;29(1):47–53.

67.

Logan

. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol. 2000;27(7):661–670.

68.

Yaqub

Tolboom

van Berckel

Scheltens

Lammertsma

Boellaard

. Simplified parametric methods for [18F]FDDNP studies. Neuroimage. 2010;49(1):433–441.

69.

Slifstein

Laruelle

. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med. 2000;41(12):2083–2088.

70.

Wong

Wardak

Shao

, et al. Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region. Eur J Nucl Med Mol Imaging. 2010;37(3):575–588.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.17 MB

Mapping Kappa Opioid Receptor Binding in Titi Monkeys with [ 11 C]GR103545 PET

Abstract

Purpose

Methods

Results

Conclusions

Keywords

Introduction

Materials and Methods

Animals

PET Imaging Protocol and Pretreatment

Magnetic Resonance Imaging (MRI) Acquisition

Image Post Processing and Kinetic Modeling

Statistical Analysis

Results

Baseline BPND Concurred with Reported Distribution of KOR in the Titi Monkey Brain

Pretreatment with CERC-501 Significantly Reduced Binding Across Several, but not all, VOIs When Compared to Baseline BPND

BPND Measured from SRTM Correlated with That from the LRTM Analysis

Discussion

Conclusions

Supplemental Material

sj-doc-1-mix-10.1177_15353508251341082 - Supplemental material for Mapping Kappa Opioid Receptor Binding in Titi Monkeys with [11C]GR103545 PET

Footnotes

Acknowledgements

ORCID iDs

Ethical considerations

Author Contributions

Funding

Declaration of Conflicting Interests

Data Availability Statement

Supplemental Material

References

Supplementary Material

Baseline BP_ND Concurred with Reported Distribution of KOR in the Titi Monkey Brain

Pretreatment with CERC-501 Significantly Reduced Binding Across Several, but not all, VOIs When Compared to Baseline BP_ND

BP_ND Measured from SRTM Correlated with That from the LRTM Analysis

sj-doc-1-mix-10.1177_15353508251341082 - Supplemental material for Mapping Kappa Opioid Receptor Binding in Titi Monkeys with [¹¹C]GR103545 PET